The table below provides the definition for this International Classification of Childhood Cancer (ICCC) variable. To see other variable definitions, see the ICCC home page.
Site Group | ICD-O-3 Site | ICD-O-3 Histology (Type) | ICD-O-3 Behavior | Extended Classification | Main Classification |
---|---|---|---|---|---|
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases | |||||
(a) Lymphoid leukemias | |||||
(a.1) Precursor cell leukemias | C000-C809 | 9835-9836 | 3 | 001 | 011 |
C420-C421, C424 | 9811-9818, 9837 | 3 | 001 | 011 | |
(a.2) Mature B-cell leukemias | C000-C809 | 9826, 9832-9833, 9940 | 3 | 002 | 011 |
C420-C421, C424 | 9823 | 3 | 002 | 011 | |
(a.3) Mature T-cell and NK cell leukemias | C000-C809 | 9831, 9834, 9948 | 3 | 003 | 011 |
C420-C421, C424 | 9827 | 3 | 003 | 011 | |
(a.4) Lymphoid leukemia, NOS | C000-C809 | 9820 | 3 | 004 | 011 |
(b) Acute myeloid leukemias | C000-C809 | 9840, 9861, 9865-9867, 9869-9874, 9891, 9895-9898, 9910-9911, 9920, 9931 | 3 | 005 | 012 |
(c) Chronic myeloproliferative diseases | C000-C809 | 9863, 9875-9876, 9950, 9960-9964 | 3 | 006 | 013 |
(d) Myelodysplastic syndrome and other myeloproliferative diseases | C000-C809 | 9945-9946, 9975, 9980, 9982-9987, 9989, 9991-9992 | 3 | 007 | 014 |
(e) Unspecified and other specified leukemias | C000-C809 | 9800-9801, 9805-9809, 9860, 9930, 9965-9967, 9971 | 3 | 008 | 015 |
II. Lymphomas and reticuloendothelial neoplasms | |||||
(a) Hodgkin lymphomas | C000-C809 | 9650-9655, 9659, 9661-9665, 9667 | 3 | 009 | 021 |
(b) Non-Hodgkin lymphomas (except Burkitt lymphoma) | |||||
(b.1) Precursor cell lymphomas | C000-C809 | 9727-9729 | 3 | 010 | 022 |
C000-C419, C422-C423, C425-C809 | 9811-9818, 9837 | 3 | 010 | 022 | |
(b.2) Mature B-cell lymphomas (except Burkitt lymphoma) | C000-C809 | 9597, 9670-9671, 9673, 9675, 9678-9680, 9684, 9688-9691, 9695, 9698-9699, 9712, 9731-9735, 9737-9738, 9761-9762, 9764-9766, 9769, 9970 | 3 | 011 | 022 |
C000-C419, C422-C423, C425-C809 | 9823 | 3 | 011 | 022 | |
(b.3) Mature T-cell and NK-cell lymphomas | C000-C809 | 9700-9702, 9705, 9708-9709, 9714, 9716-9719, 9724-9726, 9767-9768 | 3 | 012 | 022 |
C000-C419, C422-C423, C425-C809 | 9827 | 3 | 012 | 022 | |
(b.4) Non-Hodgkin lymphomas, NOS | C000-C809 | 9591, 9760 | 3 | 013 | 022 |
(c) Burkitt lymphoma | C000-C809 | 9687 | 3 | 014 | 023 |
(d) Miscellaneous lymphoreticular neoplasms | C000-C809 | 9740-9742, 9750-9759 | 3 | 015 | 024 |
(e) Unspecified lymphomas | C000-C809 | 9590, 9596 | 3 | 016 | 025 |
III. CNS and miscellaneous intracranial and intraspinal neoplasms | |||||
(a) Ependymomas and choroid plexus tumor | |||||
(a.1) Ependymomas | C000-C809 | 9383, 9391-9394 | 0,1,3 | 017 | 031 |
(a.2) Choroid plexus tumor | C000-C809 | 9390 | 0,1,3 | 018 | 031 |
(b) Astrocytomas | C723 | 9380 | 0,1,3 | 019 | 032 |
C000-C809 | 9384, 9400-9411, 9420-9424, 9440-9442 | 0,1,3 | 019 | 032 | |
(c) Intracranial and intraspinal embryonal tumors | |||||
(c.1) Medulloblastomas | C000-C809 | 9470-9472, 9474, 9480 | 0,1,3 | 020 | 033 |
(c.2) PNET | C000-C809 | 9473 | 0,1,3 | 021 | 033 |
(c.3) Medulloepithelioma | C700-C729 | 9501-9504 | 0,1,3 | 022 | 033 |
(c.4) Atypical teratoid/rhabdoid tumor | C000-C809 | 9508 | 0,1,3 | 023 | 033 |
(d) Other gliomas | |||||
(d.1) Oligodendrogliomas | C000-C809 | 9450, 9451, 9460 | 0,1,3 | 024 | 034 |
(d.2) Mixed and unspecified gliomas | C700-C722, C724-C729, C751, C753 | 9380 | 0,1,3 | 025 | 034 |
C000-C809 | 9382 | 0,1,3 | 025 | 034 | |
(d.3) Neuroepithelial glial tumors of uncertain origin | C000-C809 | 9381, 9430, 9444 | 0,1,3 | 026 | 034 |
(e) Other specified intracranial and intraspinal neoplasms | |||||
(e.1) Pituitary adenomas and carcinomas | C000-C809 | 8270-8281, 8300 | 0,1,3 | 027 | 035 |
(e.2) Tumors of the sellar region (craniopharyngiomas) | C000-C809 | 9350-9352, 9582 | 0,1,3 | 028 | 035 |
(e.3) Pineal parenchymal tumors | C000-C809 | 9360-9362 | 0,1,3 | 029 | 035 |
(e.4) Neuronal and mixed neuronal-glial tumors | C000-C809 | 9412-9413, 9492-9493, 9505-9507 | 0,1,3 | 030 | 035 |
(e.5) Meningiomas | C000-C809 | 9530-9539 | 0,1,3 | 031 | 035 |
(f) Unspecified intracranial and intraspinal neoplasms | C700-C729, C751-C753 | 8000-8005 | 0,1,3 | 032 | 036 |
IV. Neuroblastoma and other peripheral nervous cell tumors | |||||
(a) Neuroblastoma and ganglioneuroblastoma | C000-C809 | 9490, 9500 | 3 | 033 | 041 |
(b) Other peripheral nervous cell tumors | C000-C809 | 8680-8683, 8690-8693, 8700, 9520-9523 | 3 | 034 | 042 |
C000-C699, C739-C768, C809 | 9501-9504 | 3 | 034 | 042 | |
V. Retinoblastoma | C000-C809 | 9510-9514 | 3 | 035 | 050 |
VI. Renal tumors | |||||
(a) Nephroblastoma and other nonepithelial renal tumors | |||||
(a.1) Nephroblastoma | C000-C809 | 8959-8960 | 3 | 036 | 061 |
(a.2) Rhabdoid renal tumor | C649 | 8963 | 3 | 037 | 061 |
(a.3) Kidney sarcomas | C000-C809 | 8964-8967 | 3 | 038 | 061 |
(a.4) pPNET of kidney | C649 | 9364 | 3 | 039 | 061 |
(b) Renal carcinomas | C649 | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8143, 8155, 8190-8201, 8210-8211, 8221-8231, 8240-8241, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8576 | 3 | 040 | 062 |
C000-C809 | 8311-8312, 8316-8319, 8361 | 3 | 040 | 062 | |
(c) Unspecified malignant renal tumors | C649 | 8000-8005 | 3 | 041 | 063 |
VII. Hepatic tumors | |||||
(a) Hepatoblastoma | C000-C809 | 8970 | 3 | 042 | 071 |
(b) Hepatic carcinomas | C220, C221 | 8010-8041, 8050-8075, 8082, 8120-8122, 8140-8141, 8143, 8155, 8190-8201, 8210-8211, 8230, 8231, 8240-8241, 8244-8246, 8260-8264, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8576 | 3 | 043 | 072 |
C000-C809 | 8160-8180 | 3 | 043 | 072 | |
(c) Unspecified malignant hepatic tumors | C220-C221 | 8000-8005 | 3 | 044 | 073 |
VIII. Malignant bone tumors | |||||
(a) Osteosarcomas | C400-C419, C760-C768, C809 | 9180-9187, 9191-9195, 9200 | 3 | 045 | 081 |
(b) Chondrosarcomas | C400-C419, C760-C768, C809 | 9210, 9220, 9240 | 3 | 046 | 082 |
C000-C809 | 9221, 9230, 9241-9243 | 3 | 046 | 082 | |
(c) Ewing tumor and related sarcomas of bone | |||||
(c.1) Ewing tumor and Askin tumor of bone | C400-C419, C760-C768, C809 | 9260 | 3 | 047 | 083 |
C400-C419 | 9365 | 3 | 047 | 083 | |
(c.2) pPNET of bone | C400-C419 | 9363-9364 | 3 | 048 | 083 |
(d) Other specified malignant bone tumors | |||||
(d.1) Malignant fibrous neoplasms of bone | C400-C419 | 8810-8811, 8823, 8830 | 3 | 049 | 084 |
C000-C809 | 8812, 9262 | 3 | 049 | 084 | |
(d.2) Malignant chordomas | C000-C809 | 9370-9372 | 3 | 050 | 084 |
(d.3) Odontogenic malignant tumors | C000-C809 | 9270-9275, 9280-9282, 9290, 9300-9302, 9310-9312, 9320-9322, 9330, 9340-9342 | 3 | 051 | 084 |
(d.4) Miscellaneous malignant bone tumors | C000-C809 | 9250, 9261 | 3 | 052 | 084 |
(e) Unspecified malignant bone tumors | C400-C419 | 8000-8005, 8800-8801, 8803-8805 | 3 | 053 | 085 |
IX. Soft tissue and other extraosseous sarcomas | |||||
(a) Rhabdomyosarcomas | C000-C809 | 8900-8905, 8910, 8912, 8920, 8991 | 3 | 054 | 091 |
(b) Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms | |||||
(b.1) Fibroblastic and myofibroblastic tumors | C000-C399, C440-C768, C809 | 8810-8811, 8813-8815, 8821, 8823, 8834-8835 | 3 | 055 | 092 |
C000-C809 | 8820, 8822, 8824-8827, 9150, 9160 | 3 | 055 | 092 | |
(b.2) Nerve Sheath Tumors | C000-C809 | 9540-9571 | 3 | 056 | 092 |
(b.3) Other fibromatous neoplasms | C000-C809 | 9491, 9580 | 3 | 057 | 092 |
(c) Kaposi sarcoma | C000-C809 | 9140 | 3 | 058 | 093 |
(d) Other specified soft tissue sarcomas | |||||
(d.1) Ewing tumor and Askin tumor of soft tissue | C000-C399, C470-C759 | 9260 | 3 | 059 | 094 |
C000-C399, C470-C639, C659-C768, C809 | 9365 | 3 | 059 | 094 | |
(d.2) pPNET of soft tissue | C000-C399, C470-C639, C659-C699, C739-C768, C809 | 9364 | 3 | 060 | 094 |
(d.3) Extrarenal rhabdoid tumor | C000-C639, C659-C699, C739-C768, C809 | 8963 | 3 | 061 | 094 |
(d.4) Liposarcomas | C000-C809 | 8850-8858, 8860-8862, 8870, 8880-8881 | 3 | 062 | 094 |
(d.5) Fibrohistiocytic tumors | C000-C399, C440-C768, C809 | 8830 | 3 | 063 | 094 |
C000-C809 | 8831-8833, 8836, 9251-9252 | 3 | 063 | 094 | |
(d.6) Leiomyosarcomas | C000-C809 | 8890-8898 | 3 | 064 | 094 |
(d.7) Synovial sarcomas | C000-C809 | 9040-9044 | 3 | 065 | 094 |
(d.8) Blood vessel tumors | C000-C809 | 9120-9125, 9130-9133, 9135-9136, 9141-9142, 9161, 9170-9175 | 3 | 066 | 094 |
(d.9) Osseous and chondromatous neoplasms of soft tissue | C490-C499 | 9180, 9210, 9220, 9240 | 3 | 067 | 094 |
C000-C809 | 9231 | 3 | 067 | 094 | |
(d.10) Alveolar soft parts sarcoma | C000-C809 | 9581 | 3 | 068 | 094 |
(d.11) Miscellaneous soft tissue sarcomas | C000-C809 | 8587, 8710-8713, 8806, 8840-8842, 8921, 8982, 8990, 9373 | 3 | 069 | 094 |
(e) Unspecified soft tissue sarcomas | C000-C399, C440-C768, C809 | 8800-8805 | 3 | 070 | 095 |
X. Germ cell tumors, trophoblastic tumors, and neoplasms of gonads | |||||
(a) Intracranial and intraspinal germ cell tumors | |||||
(a.1) Intracranial and intraspinal germinomas | C700-C729, C751-C753 | 9060-9065 | 0,1,3 | 071 | 101 |
(a.2) Intracranial and intraspinal teratomas | C700-C729, C751-C753 | 9080-9084 | 0,1,3 | 072 | 101 |
(a.3) Intracranial and intraspinal embryonal carcinomas | C700-C729, C751-C753 | 9070, 9072 | 0,1,3 | 073 | 101 |
(a.4) Intracranial and intraspinal yolk sac tumor | C700-C729, C751-C753 | 9071 | 0,1,3 | 074 | 101 |
(a.5) Intracranial and intraspinal choriocarcinoma | C700-C729, C751-C753 | 9100 | 0,1,3 | 075 | 101 |
(a.6) Intracranial and intraspinal tumors of mixed forms | C700-C729, C751-C753 | 9085, 9101 | 0,1,3 | 076 | 101 |
(b) Malignant extracranial and extragonadal germ cell tumors | |||||
(b.1) Malignant germinomas of extracranial and extragonadal sites | C000-C559, C570-C619, C630-C699, C739-C750, C754-C768, C809 | 9060-9065 | 3 | 077 | 102 |
(b.2) Malignant teratomas of extracranial and extragonadal sites | C000-C559, C570-C619, C630-C699, C739-C750, C754-C768, C809 | 9080-9084 | 3 | 078 | 102 |
(b.3) Embryonal carcinomas of extracranial and extragonadal sites | C000-C559, C570-C619, C630-C699, C739-C750, C754-C768, C809 | 9070, 9072 | 3 | 079 | 102 |
(b.4) Yolk sac tumor of extracranial and extragonadal sites | C000-C559, C570-C619, C630-C699, C739-C750, C754-C768, C809 | 9071 | 3 | 080 | 102 |
(b.5) Choriocarcinomas of extracranial and extragonadal sites | C000-C559, C570-C619, C630-C699, C739-C750, C754-C768, C809 | 9100, 9103-9104 | 3 | 081 | 102 |
(b.6) Other and unspecified malignant mixed germ cell tumors of extracranial and extragonadal sites | C000-C559, C570-C619, C630-C699, C739-C750, C754-C768, C809 | 9085, 9101-9102, 9105 | 3 | 082 | 102 |
(c) Malignant gonadal germ cell tumors | |||||
(c.1) Malignant gonadal germinomas | C569, C620-C629 | 9060-9065 | 3 | 083 | 103 |
(c.2) Malignant gonadal teratomas | C569, C620-C629 | 9080-9084, 9090-9091 | 3 | 084 | 103 |
(c.3) Gonadal embryonal carcinomas | C569, C620-C629 | 9070, 9072 | 3 | 085 | 103 |
(c.4) Gonadal yolk sac tumor | C569, C620-C629 | 9071 | 3 | 086 | 103 |
(c.5) Gonadal choriocarcinoma | C569, C620-C629 | 9100 | 3 | 087 | 103 |
(c.6) Malignant gonadal tumors of mixed forms | C569, C620-C629 | 9085, 9101 | 3 | 088 | 103 |
(c.7) Malignant gonadal gonadoblastoma | C569, C620-C629 | 9073 | 3 | 089 | 103 |
(d) Gonadal carcinomas | C569, C620-C629 | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8143, 8190-8201, 8210-8211, 8221-8241, 8244-8246, 8260-8263, 8290, 8310, 8313, 8320, 8323, 8380-8384, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573, 9000, 9014, 9015 | 3 | 090 | 104 |
C000-C809 | 8441-8444, 8450-8451, 8460-8473 | 3 | 090 | 104 | |
(e) Other and unspecified malignant gonadal tumors | C000-C809 | 8590-8671 | 3 | 091 | 105 |
C569, C620-C629 | 8000-8005 | 3 | 091 | 105 | |
XI. Other malignant epithelial neoplasms and malignant melanomas | |||||
(a) Adrenocortical carcinomas | C000-C809 | 8370-8375 | 3 | 092 | 111 |
(b) Thyroid carcinomas | C739 | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8190, 8200-8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480-8481, 8510, 8560-8573 | 3 | 093 | 112 |
C000-C809 | 8330-8337, 8340-8347, 8350 | 3 | 093 | 112 | |
(c) Nasopharyngeal carcinomas | C110-C119 | 8010-8041, 8050-8075, 8082-8083, 8120-8122, 8130-8141, 8190, 8200-8201, 8211, 8230-8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480-8481, 8500-8576 | 3 | 094 | 113 |
(d) Malignant melanomas | C000-C809 | 8720-8780, 8790 | 3 | 095 | 114 |
(e) Skin carcinomas | C440-C449 | 8010-8041, 8050-8075, 8078, 8082, 8090-8110, 8140, 8143, 8147, 8190, 8200, 8240, 8246-8247, 8260, 8310, 8320, 8323, 8390-8420, 8430, 8480, 8542, 8560, 8570-8573, 8940, 8941 | 3 | 096 | 115 |
(f) Other and unspecified carcinomas | |||||
(f.1) Carcinomas of salivary glands | C079-C089 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 097 | 116 |
(f.2) Carcinomas of colon and rectum | C180, C182-C189, C199, C209, C210-C218 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 098 | 116 |
(f.3) Carcinomas of appendix | C181 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 099 | 116 |
(f.4) Carcinomas of lung | C340-C349 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 100 | 116 |
(f.5) Carcinomas of thymus | C379 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 101 | 116 |
(f.6) Carcinomas of breast | C500-C509 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 102 | 116 |
(f.7) Carcinomas of cervix uteri | C530-C539 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 103 | 116 |
(f.8) Carcinomas of bladder | C670-C679 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 104 | 116 |
(f.9) Carcinomas of eye | C690-C699 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 105 | 116 |
(f.10) Carcinomas of other specified sites | C000-C069, C090-C109, C129-C179, C239-C339, C380-C399, C480-C488, C510-C529, C540-C549, C559, C570-C619, C630-C639, C659-C669, C680-C689, C700-C729, C750-C759 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 106 | 116 |
(f.11) Carcinomas of unspecified site | C760-C768, C809 | 8010-8084, 8120-8157, 8190-8264, 8290, 8310, 8313-8315, 8320-8325, 8360, 8380-8384, 8430-8440, 8452-8454, 8480-8586, 8588-8589, 8940-8941, 8983, 9000, 9010-9016, 9020, 9030 | 3 | 107 | 116 |
XII. Other and unspecified malignant neoplasms | |||||
(a) Other specified malignant tumors | |||||
(a.1) Gastrointestinal stromal tumor | C000-C809 | 8936 | 3 | 108 | 121 |
(a.2) Pancreatoblastoma | C000-C809 | 8971 | 3 | 109 | 121 |
(a.3) Pulmonary blastoma and pleuropulmonary blastoma | C000-C809 | 8972-8973 | 3 | 110 | 121 |
(a.4) Other complex mixed and stromal neoplasms | C000-C809 | 8930-8935, 8950-8951, 8974-8981 | 3 | 111 | 121 |
(a.5) Mesothelioma | C000-C809 | 9050-9055 | 3 | 112 | 121 |
(a.6) Other specified malignant tumors | C000-C809 | 9110 | 3 | 113 | 121 |
C000-C399, C470-C759 | 9363 | 3 | 113 | 121 | |
(b) Other unspecified malignant tumors | C000-C218, C239-C399, C420-C559, C570-C619, C630-C639, C659-C699, C739-C750, C754-C809 | 8000-8005 | 3 | 114 | 122 |
* This table was updated for Hematopoietic codes based on WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008).
^ Subject to change based on evolving ICD-O-3 coding rules.